FDA approves new indication for Xtandi
September 11, 2014Sales and Marketing Astellas, FDA, Medivation, Xtandi, Zytiga, prostate
The FDA has approved Astellas Pharma and Medivation’s prostate cancer drug Xtandi (enzalutamide) for use in patients who have not …
Fourth diet pill makes it to US market
September 11, 2014Manufacturing and Production, Sales and Marketing Contrave, FDA, Orexigen Therapeutics, diet, obesity
Orexigen Therapeutics has gained FDA approval for its new obesity treatment Contrave to help overweight patients reduce their food intake. …
90TEN Healthcare appoints comms director
September 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Lottie Tupholme, Peter Impey, Steve Ramsey
London comms agency 90TEN Healthcare has hired Peter Impey as its director of international communications, and added two heads to …
NICE seeks more trial data from pharma
September 10, 2014Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency
NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …
InterMune’s IPF drug shines at ERS Congress
September 10, 2014Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, IPF, InterMune, idiopathic pulmonary fibrosis, munich, pirfenidone
InterMune has posted positive data for its lung-scarring drug at this year’s European Respiratory Society Annual Congress 2014 (ERS). Pharmafile …
Apple launches health-centred smartwatch
September 10, 2014Medical Communications, Research and Development, Sales and Marketing Android, Apple, Jobs, Samsung, apple watch, google, health kit
Apple has finally unveiled its long-rumoured ‘smartwatch’ to the world along with new iPhones and a payment system. At the …
Trial misconduct halts Evotec/Hyperion drug
September 10, 2014Research and Development, Sales and Marketing DiaPep277, Evotec, amdromeda, diabetes, hyperion
Development of Evotec and Hyperion Therapeutic’s diabetes drug DiaPep277 has been terminated following ‘serious misconduct’ in one of its trials. …
Liberation appoints account co-ordinator
September 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Mullin, Liberation, communications
UK-based healthcare comms agency Liberation has hired a new starter to its team with the appointment of Edward Mullin as …
Federal Trade Commission sues AbbVie and Teva
September 9, 2014Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission
Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …
‘Pocket doctor’ on the horizon for Parkinson’s
September 9, 2014Medical Communications, Sales and Marketing Nonlinearity and Complexity Research Group, Parkinson's, aston, dr little, pocket doctor
Smartphones will soon be able to perform the functions of a ‘pocket doctor’ and map Parkinson’s disease and other degenerative …
Celgene rebuffed by NICE over cancer drug
September 9, 2014Sales and Marketing Abraxane, Cancer, Celgene, Gemzar, NICE, gemcitabine, nab-paclitaxel
In new draft guidance NICE says that Celgene’s Abraxane (nab-paclitaxel) taken with Lilly’s Gemzar (gemcitabine) should not be funded by …
New chief executive and chairman for Evaluate
September 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing alex karle, evaluate
Life science market intelligence firm Evaluate has appointed Alex Karle to the role of chief executive, replacing the firm’s founder Dr …
New chief executive for ReNeuron
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Olav Hellebø, ReNeuron, clavis
UK-based stem cell therapy firm ReNeuron has appointed Olav Hellebø to be its new chief executive. Since starting his pharma …
NHS cancer services not holding up, says report
September 8, 2014Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, government, oncology
NHS cancer services are in urgent need of investment and review, according to a new report commissioned by Cancer Research …
Servier slammed over UK trial transparency failure
September 8, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, PMCPA, Servier, code, conduct, transparancy, trials
Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …
BMS sues Merck over new melanoma drug
September 8, 2014Research and Development, Sales and Marketing BMS, FDA, Merck, PD-1 inhibitors, Yervoy, keytruda
Things are getting ugly between Bristol-Myers Squibb and Merck as the former company began legal proceedings against the latter over …
MHRA leads social media drug safety initiative
September 8, 2014Medical Communications, Sales and Marketing EFPIA, EU, MHRA, social media, web-radr
The MHRA has announced that it is to lead European medicines regulators, academics and pharma in a three-year project to …
Bristol-Myers Squibb: following the string of pearls
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions
Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …
Theraclion hires chief executive and VP
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anja Kleber, David Caumartin, Theraclion
French medical device firm Theraclion has appointed David Caumartin as its chief executive and Anja Kleber as vice president of …
Sanofi releases new diabetes app for children
September 5, 2014Medical Communications, Sales and Marketing Gamification, Lilly board game, Sanofi, Syrum, monster manor
Sanofi Diabetes has launched a new mobile game aimed at educating children, teachers, parents and carers about living with type …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
